Displaying 1181 - 1200 of 1618
Maintaining Competition, FTC Allows Fresenius $3.5 Billion Deal to Buy Rival Dialysis Provider Renal Care Group
Date
Fresenius AG will sell 91 outpatient kidney dialysis clinics and financial interests in 12 more to settle Federal Trade Commission charges that Fresenius’ purchase of rival dialysis provider Renal...
FTC Proposes Study of Competitive Impacts of Authorized Generic Drugs
Date
The Federal Trade Commission today announced its intention to conduct a study of the use, and likely short- and long-term competitive effects, of authorized generics in the prescription drug...
Hospitals Plan for Collective Bargaining of Physicians Fees Likely Would Violate Federal Laws, FTC Staff Says
Date
A proposed plan by a physician-hospital organization that would involve collective bargaining with insurers over doctor fees likely would violate federal antitrust laws, according to the FTC staff...
Health Care Alliance of Laredo, L.C., In the Matter of
A physicians’ independent practice association in Texas agreed to settle charges that it engaged in unlawful collective bargaining to set fees its members would accept from health insurance plans and advised its members against dealing individually with plans. The Commission charged that both practices resulted in higher medical costs for consumers. The consent order settling the FTC’s charges will prohibit the IPA from engaging in such anticompetitive conduct in the future.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410097
Preserving Competition, FTC Requires Divestiture Before Allowing Allergans Acquisition of Inamed
Date
Botox marketer Allergan, Inc., and the Inamed Corporation will divest the rights to develop and distribute Reloxin, a potential Botox rival, to settle Federal Trade Commission charges that Allergan’s...
Teva Pharmaceutical Industries Ltd. and IVAX Corporation, In the Matter of
The consent order allowed Teva to acquire IVAX Corporation, provided the companies sell the rights and assets needed to manufacture and market 15 generic pharmaceutical products. Among the drugs sold were several forms of generic amoxicillin and amoxicillin clavulanate potassium that are widely used in the United States.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
051 0214
Docket Number
C-4155
FTC Staff Files Comments on New Jerseys Proposed Advertising Guideline 4; Commission Finalizes Teva/Ivax Consent Order
Date
Commission authorization of the filing of staff comment:The Commission has authorized the staffs of the Bureau of Consumer Protection, Bureau of Economics, and Office of Policy Planning to file a...
Texas Doctors' IPA Agrees to Settle Price Fixing Charges
Date
A physicians’ independent practice association (IPA) in Texas has agreed to settle Federal Trade Commission charges that it engaged in unlawful collective bargaining to set fees its members would...
Davita Inc. Submits Petition for Approval of Proposed Divestiture; FTC Submits Budget Request and Performance Plans to Congress
Date
Petition for proposed divestiture: The Commission has received a petition from DaVita Inc. (DaVita) requesting approval of a proposed divestiture related to its recent acquisition of Gambro Healthcare...
Announced Action for January 27, 2006
Date
Commission authorization of the filing of staff comment: The Commission has authorized the staffs of the Office of Policy Planning, Bureau of Consumer Protection, and Bureau of Economics to file a...
Preserving Competition, FTC Requires Divestitures Before Allowing Tevas $7.4 Billion Acquisition of IVAX
Date
Under a consent agreement announced today, the Federal Trade Commission will allow Teva Pharmaceutical Industries Ltd.’s (Teva) proposed acquisition of IVAX Corporation (IVAX), provided the companies...
Commission Finds That North Texas Specialty Physicians Illegally Fixed Prices
Date
In a unanimous administrative opinion and order made public today, the Federal Trade Commission ruled that North Texas Specialty Physicians (NTSP), an association of independent physicians in the...
In re Tamoxifen Citrate Antitrust Litigation
Date
Citation Number
03-7641
Federal Court
U.S. Circuit Court of Appeals for the Second Circuit
An amicus brief in support of plaintiffs-appellants’ petition for panel rehearing and rehearing en banc. The case concerns a decision by a divided panel of the appeals court upholding the dismissal...
File
In re Tamoxifen Citrate Antitrust Litigation
(133.21 KB)
Announced Action for November 18, 2005
Date
Commission approval of final consent order: Following a public comment period, the Commission has approved the issuance of a final consent order in the matter concerning DaVita, Inc. and Gambro AB...
FTC Sues to Stop Anticompetitive Agreement in U.S. Drug Industry
Date
The Federal Trade Commission today filed a complaint in federal district court seeking to put an end to an agreement between drug manufacturers Galen Chemicals Ltd. (now known as Warner Chilcott) and...
Administrative Law Judge Orders Evanston Northwestern Healthcare Corporation to Sell Highland Park Hospital
Date
Evanston Northwestern Healthcare Corporation (ENH), located in Evanston, Illinois, must sell Highland Park Hospital (Highland Park) within 180 days, under the terms of an initial decision and order...
FTC Accepts Settlement to Remedy DaVita's Acquisition of Rival Outpatient Dialysis Clinic Provider Gambro
Date
The Federal Trade Commission today accepted for public comment an order resolving the competitive issues raised by DaVita, Inc.’s (DaVita) proposed $3.1 billion purchase of rival outpatient dialysis...
Public Statement
Health Care: An Interview with Commissioner Thomas B. Leary
Date
This is an interview with Commissioner Leary conducted by the ABA Antitrust Section Health Care Committee Newsletter, published in the ABA's Antitrust Health Care Chronicle, October 2005, Vol. 19, No...
File
Partners Health Network, Inc., In the Matter of
A physician-hospital organization operating in northwestern South Carolina, agreed to settle charges that it orchestrated and carried out agreements among its physician members to set the prices they would accept from health plans, and to refuse to deal
with health plans that did not agree to its collectively determined prices. The consent order settling the FTC’s charges prohibits the PHO from collectively negotiating with health plans on behalf of its physicians and from setting terms of dealing with purchasers.
Type of Action
Administrative
Last Updated
FTC Matter/File Number
0410100
Displaying 1181 - 1200 of 1618